Q3 2024 Holdings
Filed 2024-11-14 | 18 holdings | $282.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $89.6M | 1,793,866 | 31.8% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $63.8M | 5,187,191 | 22.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $39.2M | 6,880,527 | 13.9% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $28.1M | 4,195,894 | 9.9% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $26.0M | 5,224,600 | 9.2% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $17.4M | 6,202,374 | 6.2% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $6.9M | 410,830 | 2.4% |
| Passage BIO Inc | COM | 702712100 | $5.9M | 8,426,955 | 2.1% |
| Ibio Inc(IBIO) | CON NEW | 451033708 | $1.9M | 862,279 | 0.7% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $1.3M | 680,189 | 0.5% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $707.8K | 271,177 | 0.3% |
| Pieris Pharmaceuticals Inc | COM NEW | 720795202 | $620.7K | 37,436 | 0.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $278.2K | 17,400 | 0.1% |
| Bionomics Limited(BNOXN) | ADS | 09063M205 | $241.5K | 549,673 | 0.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $205.7K | 8,231 | 0.1% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $51.0K | 14,751 | 0.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $32.5K | 19,028 | 0.0% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $30.4K | 16,194 | 0.0% |